The Carlyle Group Investing Cash Flow increased by 33.1% to -$28.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 68.3%, from -$16.70M to -$28.10M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 45.6% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.00M | -$6.10M | -$14.40M | -$630.70M | -$5.10M | -$227.40M | $0.00 | -$93.90M | -$29.20M | -$14.20M | -$22.70M | -$14.00M | -$26.70M | -$16.70M | -$17.50M | -$23.20M | -$42.00M | -$28.10M |
| QoQ Change | — | -205.0% | -136.1% | <-999% | +99.2% | <-999% | +100.0% | — | +68.9% | +51.4% | -59.9% | +38.3% | -90.7% | +37.5% | -4.8% | -32.6% | -81.0% | +33.1% |
| YoY Change | — | — | — | — | -155.0% | <-999% | +100.0% | +85.1% | +87.2% | +84.9% | — | +52.1% | — | -17.6% | +22.9% | -65.7% | -57.3% | -68.3% |